319
Participants
Start Date
October 16, 2014
Primary Completion Date
October 24, 2016
Study Completion Date
October 24, 2016
Placebo
Placebo intravaginal ring (treatment for 84 days, 28 days wearing period for each ring) and Placebo 3-months depot intramuscular injection
Levonorgestrel
Levonorgestrel 40 µg/d intravaginal ring (treatment for 84 days, 28 days wearing period for each ring) and Placebo 3-months depot intramuscular injection
Anastrozole
Participants received Anastrozole 300 µg/d or 600 µg/d or 1050 µg/d + Levonorgestrel 40 µg/d intravaginal ring (treatment for 84 days, 28 days wearing period for each ring) and Placebo 3-months depot intramuscular injection
Lupron / Leuprolide acetate
Placebo intravaginal ring (treatment for 84 days, 28 days wearing period for each ring) and Lupron / Leuprolide acetate 11.25 mg 3-months depot intramuscular injection
Bruxelles - Brussel
Lausanne
Bruxelles - Brussel
Vienna
Asker
Copenhagen
Edegem
Bern
Tønsberg
Linz
Lucerne
Innsbruck
Trondheim
Barcelona
Aarhus N
Stokmarknes
Ghent
Tromsø
Villach
Berlin
Berlin
Philadelphia
Hamburg
Turku
Hamburg
Winston-Salem
Greensboro
Durham
Aravaca
Pozuelo de Alarcón
Collado Villalba
Sandy Springs
Atlanta
Gainesville
New Port Richey
České Budějovice
Chattanooga
Blankenburg
Tábor
Písek
Jyväskylä
Seville
Columbus
Dayton
Valencia
Valencia
Detroit
Canton
Saginaw
Cologne
Aachen
Madison
Palos Heights
Chicago
Wichita
Mannheim
Lincoln
Marrero
Kuopio
Karlsruhe
München
Oulu
Erlangen
San Diego
Seattle
San Francisco
Neptune City
Plainsboro
Hamilton
Ottawa
Toronto
Montreal
Québec
Brno
Brno
Hradec Králové
Olomouc
Pilsen
Prague
Almere Stad
Frauenklinik
Odense C
Espoo
Helsinki
Hyvinkää
Dippoldiswalde
Dresden
Bernburg
Jena
Kitakyushu
Sapporo
Sapporo
Sapporo
Sapporo
Kawanishi
Kanazawa
Kurashiki
Sayama
Hamamatsu
Bunkyo-ku
Minatoku
Shinagawa-ku
Kumamoto
Nagano
Osaka
Groningen
Nieuwegein
Zwolle
Bialystok
Katowice
Krakow
Lodz
Lublin
Szczecin
Łęczna
Barcelona
Vitoria-Gasteiz
Lead Sponsor
Bayer
INDUSTRY